中国医院用药评价与分析
中國醫院用藥評價與分析
중국의원용약평개여분석
EVALUATION AND ANAL YSIS OF DRUG-USE IN HOSPITALS OF CHINA
2014年
9期
831-833,834
,共4页
王萌萌%庞艳玉%王先利%曾涛%杨振宇
王萌萌%龐豔玉%王先利%曾濤%楊振宇
왕맹맹%방염옥%왕선리%증도%양진우
药品说明书%妊娠%哺乳%标注%合理用药
藥品說明書%妊娠%哺乳%標註%閤理用藥
약품설명서%임신%포유%표주%합리용약
Drug package insert%Pregnancy%Lactation%Labeling%Rational use of drug
目的:了解药品说明书中有关妊娠期及哺乳期妇女用药的标注情况,促进药品说明书规范化管理,为临床安全用药提供参考依据。方法:收集我院调剂药房药品说明书,对有关妊娠期及哺乳期妇女用药标注情况进行统计分析,按照不同分类方法进行比较。结果:所调查的药品说明书中,国产化学药及生物制品有关妊娠期及哺乳期妇女用药标注率分别为95.91%和80.56%,进口药为98.02%和87.13%,国产中成药为68.38%和6.84%。妊娠期及哺乳期妇女用药无明确指导意见的分别占26.11%和49.26%。“权衡利弊”“慎用”及“遵医嘱”等类似表述在用药指导建议中最为常见。结论:药品监管部门、生产企业和医疗卫生机构应重视目前部分药品说明书标注存在的问题,积极采取措施加以改进和完善。
目的:瞭解藥品說明書中有關妊娠期及哺乳期婦女用藥的標註情況,促進藥品說明書規範化管理,為臨床安全用藥提供參攷依據。方法:收集我院調劑藥房藥品說明書,對有關妊娠期及哺乳期婦女用藥標註情況進行統計分析,按照不同分類方法進行比較。結果:所調查的藥品說明書中,國產化學藥及生物製品有關妊娠期及哺乳期婦女用藥標註率分彆為95.91%和80.56%,進口藥為98.02%和87.13%,國產中成藥為68.38%和6.84%。妊娠期及哺乳期婦女用藥無明確指導意見的分彆佔26.11%和49.26%。“權衡利弊”“慎用”及“遵醫囑”等類似錶述在用藥指導建議中最為常見。結論:藥品鑑管部門、生產企業和醫療衛生機構應重視目前部分藥品說明書標註存在的問題,積極採取措施加以改進和完善。
목적:료해약품설명서중유관임신기급포유기부녀용약적표주정황,촉진약품설명서규범화관리,위림상안전용약제공삼고의거。방법:수집아원조제약방약품설명서,대유관임신기급포유기부녀용약표주정황진행통계분석,안조불동분류방법진행비교。결과:소조사적약품설명서중,국산화학약급생물제품유관임신기급포유기부녀용약표주솔분별위95.91%화80.56%,진구약위98.02%화87.13%,국산중성약위68.38%화6.84%。임신기급포유기부녀용약무명학지도의견적분별점26.11%화49.26%。“권형리폐”“신용”급“준의촉”등유사표술재용약지도건의중최위상견。결론:약품감관부문、생산기업화의료위생궤구응중시목전부분약품설명서표주존재적문제,적겁채취조시가이개진화완선。
OBJECTIVE:To investigate the labeling on drug use for pregnant and lactating women so as to facilitate the stan-dardized management on drug package inserts and provide reference for clinical rational use of drugs. METHODS:The drug pack-age inserts in dispensing pharmacy of our hospital were reviewed with the labeling of drug use for pregnant and lactating women an-alyzed statistically and compared in accordance with different classification methods. RESULTS:Of all the package inserts investi-gated,labeling on drug use for pregnant and lactating women was noted in the package inserts of 95.91% vs. 80.56% of domestic chemical drugs and biological products,98.02% vs. 87.13% of the imported drugs and 68.38% vs. 6.84% of the Chinese patent medicines. There was no clear labeling on drug use for pregnant and lactating women in 26.11% vs. 49.26%. The most common in-structions labeled included“weigh the merits and demerits”,“be used with caution”,“follow the doctor’s advice”and other simi-lar statements. CONCLUSIONS:Drug control authorities,drug manufacturers and medical institutions should pay attention to the problems noted in the labeling for pregnant and lactating women and take actively measures to improve and perfect drug labeling.